Related Experiment Videos
Blood brain barrier permeability in multiple sclerosis using labelled DTPA with PET, CT and MRI
Journal of Neurology, Neurosurgery, and Psychiatry
|August 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The effect of the Australian bushfires and the COVID-19 pandemic on health behaviours in people with multiple sclerosis.
Multiple sclerosis and related disorders·2021
Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes.
European journal of neurology·2018
Association of serum Cystatin C with neuromyelitis optica spectrum disorders.
European journal of neurology·2018
Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis.
Data in brief·2017
The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis.
Journal of autoimmunity·2017
Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.
Journal of neurology, neurosurgery, and psychiatry·2026
Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.
Journal of neurology, neurosurgery, and psychiatry·2026
Epilepsy and education: a nationwide cohort study.
Journal of neurology, neurosurgery, and psychiatry·2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.
Journal of neurology, neurosurgery, and psychiatry·2026
Iatrogenic cerebral amyloid angiopathy: a scoping review.
Journal of neurology, neurosurgery, and psychiatry·2026
Associations of self-reported and objectively measured physical activity and amyotrophic lateral sclerosis risk.
Journal of neurology, neurosurgery, and psychiatry·2026
Real-world effectiveness of abrocitinib and upadacitinib in atopic dermatitis: a propensity-matched analysis.
The Journal of dermatological treatment·2026
Efficacy and Safety of Ultra-Low Starting Dose Febuxostat Titration in Male Patients With Primary Gout.
International journal of rheumatic diseases·2026